IDOL research project - positive in vitro data available
Lung cancer is one of the most common cancers in Germany and at the same time has a particularly high mortality rate. One of the reasons for this is that lung tumors are often drug-resistant, which prevents chemotherapy from being successful.
A team of experts from Baden-Württemberg, consisting of hospital representatives, researchers and industry partners, has therefore joined forces as part of a project funded by the German Federal Ministry of Economics and Climate Protection to develop a novel AI-supported testing procedure that should allow individualized therapy approaches for lung cancer in the future.
Continue reading here.
![](/fileadmin/_processed_/a/f/csm_IDOL_A549_PLA_e49f10ca2b.jpg)
Date:
26.05.2023Categories:
Aktuelles, PressContact
![](/fileadmin/_processed_/b/b/csm_Martin_Kriebel-0761_cr_40405187d1.jpg)